Borjan, J., Shelburne, S. A., Shelburne, S. A., Bhatti, M. M., Aitken, S. L., & Aitken, S. L. (2019). 2246. Improved Outcomes for Cancer Patients Treated With Ceftazidime–Avibactam vs. Polymyxin-Containing Regimens for Carbapenem-Resistant Enterobacteriaceae Bacteremia. Open Forum Infect Dis.
Παραπομπή Chicago StyleBorjan, Jovan, Samuel A. Shelburne, Samuel A. Shelburne, Micah M. Bhatti, Samuel L. Aitken, και Samuel L. Aitken. "2246. Improved Outcomes for Cancer Patients Treated With Ceftazidime–Avibactam Vs. Polymyxin-Containing Regimens for Carbapenem-Resistant Enterobacteriaceae Bacteremia." Open Forum Infect Dis 2019.
Παραπομπή MLABorjan, Jovan, et al. "2246. Improved Outcomes for Cancer Patients Treated With Ceftazidime–Avibactam Vs. Polymyxin-Containing Regimens for Carbapenem-Resistant Enterobacteriaceae Bacteremia." Open Forum Infect Dis 2019.